Volume | 2,518 |
|
|||||
News | - | ||||||
Day High | 8.57 | Low High |
|||||
Day Low | 8.45 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Talis Biomedical Corporation | TLIS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
8.57 | 8.45 | 8.57 | 8.29 | 8.60 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
119 | 2,518 | US$ 8.46 | US$ 21,301 | - | 4.35 - 9.60 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:04 | 5 | US$ 8.29 | USD |
Talis Biomedical Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.39M | 1.82M | - | 2.13M | -62.01M | -34.05 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Talis Biomedical News
Date | Time | Source | News Article |
---|---|---|---|
5/08/2024 | 07:04 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
1/26/2024 | 15:33 | Edgar (US Regulatory) | Form 8-K - Current report |
11/14/2023 | 07:00 | GlobeNewswire Inc. | Talis Biomedical Announces Exploration of Strategic.. |
9/01/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
8/10/2023 | 16:01 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
8/10/2023 | 15:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/10/2023 | 15:11 | Edgar (US Regulatory) | Form 8-K - Current report |
8/10/2023 | 15:05 | GlobeNewswire Inc. | Talis Biomedical Announces Second Quarter 2023 Financial.. |
8/03/2023 | 07:00 | GlobeNewswire Inc. | Talis Biomedical to Report Second Quarter 2023 Financial.. |
8/02/2023 | 07:18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
8/02/2023 | 07:17 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
8/02/2023 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TLIS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.17 | 9.25 | 8.45 | 8.83 | 6,970 | -0.88 | -9.60% |
1 Month | 8.75 | 9.5299 | 8.45 | 9.02 | 5,379 | -0.46 | -5.26% |
3 Months | 8.9999 | 9.60 | 7.5001 | 8.82 | 7,276 | -0.7099 | -7.89% |
6 Months | 8.19 | 9.60 | 7.01 | 8.44 | 8,253 | 0.10 | 1.22% |
1 Year | 7.125 | 9.60 | 4.35 | 7.46 | 19,010 | 1.17 | 16.35% |
3 Years | 151.20 | 193.20 | 4.35 | 56.31 | 125,469 | -142.91 | -94.52% |
5 Years | 435.00 | 507.90 | 4.35 | 89.64 | 139,669 | -426.71 | -98.09% |
Talis Biomedical Description
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. |